Germ cell tumour subtypes display differential expression of microRNA371a-3p
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Germ cell tumour subtypes display differential expression of microRNA371a-3p
Authors
Keywords
-
Journal
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES
Volume 373, Issue 1748, Pages 20170338
Publisher
The Royal Society
Online
2018-04-23
DOI
10.1098/rstb.2017.0338
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Serum Levels of MicroRNA miR-371a-3p: A Sensitive and Specific New Biomarker for Germ Cell Tumours
- (2017) Klaus-Peter Dieckmann et al. EUROPEAN UROLOGY
- Testicular Germ Cell Tumors Go Epigenetics: Will miR-371a-3p Replace Classical Serum Biomarkers?
- (2017) Rui Henrique et al. EUROPEAN UROLOGY
- The epigenetics of testicular germ cell tumors: looking for novel disease biomarkers
- (2017) Ana Laura Costa et al. Epigenomics
- The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs—Part A: Renal, Penile, and Testicular Tumours
- (2016) Holger Moch et al. EUROPEAN UROLOGY
- miR-223-3p regulates cell growth and apoptosis via FBXW7 suggesting an oncogenic role in human testicular germ cell tumors
- (2016) Jikai Liu et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Accurate primary germ cell cancer diagnosis using serum based microRNA detection (ampTSmiR test)
- (2016) Ton van Agthoven et al. Oncotarget
- A pipeline to quantify serum and cerebrospinal fluid microRNAs for diagnosis and detection of relapse in paediatric malignant germ-cell tumours
- (2015) Matthew J Murray et al. BRITISH JOURNAL OF CANCER
- Circulating Serum miRNA (miR-367-3p, miR-371a-3p, miR-372-3p and miR-373-3p) as Biomarkers in Patients with Testicular Germ Cell Cancer
- (2015) Isabella Syring et al. JOURNAL OF UROLOGY
- Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
- (2014) Jacques Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- Testicular cancer: biology and biomarkers
- (2014) Leendert H. J. Looijenga et al. VIRCHOWS ARCHIV
- Identification of known and novel germ cell cancer-specific (embryonic) miRs in serum by high-throughput profiling
- (2014) M. A. Rijlaarsdam et al. Andrology
- MicroRNA miR-371a-3p in serum of patients with germ cell tumours: evaluations for establishing a serum biomarker
- (2014) M. Spiekermann et al. Andrology
- Targeted serum miRNA (TSmiR) test for diagnosis and follow-up of (testicular) germ cell cancer patients: A proof of principle
- (2013) Ad J.M. Gillis et al. Molecular Oncology
- MicroRNAs miR-371-3 in serum as diagnostic tools in the management of testicular germ cell tumours
- (2012) K-P Dieckmann et al. BRITISH JOURNAL OF CANCER
- Serum Levels of MicroRNAs miR-371-3: A Novel Class of Serum Biomarkers for Testicular Germ Cell Tumors?
- (2012) Gazanfer Belge et al. EUROPEAN UROLOGY
- MicroRNA expression profiles of seminoma from paraffin-embedded formalin-fixed tissue
- (2012) Z. Bing et al. VIRCHOWS ARCHIV
- β-Catenin/LEF1 transactivates the microRNA-371-373 cluster that modulates the Wnt/β-catenin-signaling pathway
- (2011) A-D Zhou et al. ONCOGENE
- The American Joint Committee on Cancer: the 7th Edition of the AJCC Cancer Staging Manual and the Future of TNM
- (2010) Stephen B. Edge et al. ANNALS OF SURGICAL ONCOLOGY
- Malignant Germ Cell Tumors Display Common MicroRNA Profiles Resulting in Global Changes in Expression of Messenger RNA Targets
- (2010) Roger D. Palmer et al. CANCER RESEARCH
- American Society of Clinical Oncology Clinical Practice Guideline on Uses of Serum Tumor Markers in Adult Males With Germ Cell Tumors
- (2010) Timothy D. Gilligan et al. JOURNAL OF CLINICAL ONCOLOGY
- Characterization of microRNAs Involved in Embryonic Stem Cell States
- (2010) Bradford Stadler et al. STEM CELLS AND DEVELOPMENT
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started